2026 / 02

DOI: 10.24075/medet.2026.012
Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

REVIEW

Pre-birth pharmacogenetics: personalized pharmacotherapy, the burden of knowledge and ethics of a parental decision

Demarina SM , Usolkin AA , Balashova YD , Tikhomirova SV
About authors

Yaroslavl State Medical University, Yaroslavl, Russia

Correspondence should be addressed: Svetlana M Demarina
Revolyutsionnaya St, 5, Yaroslavl, 150000, Russia; ur.xednay@msguhc

About paper

Author contribution: Demarina SM — literature selection and analysis; writing and editing the manuscript; Usolkin AA — literature selection and analysis; writing the manuscript; Balashova YD — literature selection and analysis; writing the manuscript; Tikhomirova SV — manuscript editing.

Received: 2026-03-19 Accepted: 2026-04-17 Published online: 2026-05-23
|
  1. Baranov VS. Polimorfizm genov, ekogeneticheskiye bolezni i geneticheskiy pasport. Ekologicheskaya Genetika. 2011; 9(3): 3–14. Russian
  2. Baranov VS. Genomika na puti k prediktivnoy meditsine. Acta Naturae. 2009; 1(3): 77–88. Russian.
  3. Baranov VS, ed. Geneticheskiy pasport — osnova individual’noy i prediktivnoy meditsiny. Saint Petersburg. Izd-vo N-L. 2009; 528 p. Russian
  4. Solomon BD, Jack BW, Feero WG. The clinical content of preconception care: genetics and genomics. Am J Obstet Gynecol. 2008; 199(6 Suppl 2): S340–S344.
  5. Raymond M, Critchlow J, Rice SM, et al. Fetal pharmacogenomics: a promising addition to complex neonatal care. Mol Genet Metab. 2022; 137(1–2): 140–145.
  6. Kihlbom U. Ethical issues in preconception genetic carrier screening. Ups J Med Sci. 2016; 121(4): 295–298.
  7. Council of Europe. Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine (Oviedo Convention). Oviedo; 1997. Available from: https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/164 (accessed: 18.03.2026).
  8. Kaye DK. Addressing ethical issues related to prenatal diagnostic procedures. Matern Health Neonatol Perinatol. 2023; 9(1): 1.
  9. De Wert GM, Dondorp WJ, Knoppers BM. Preconception care and genetic risk: ethical issues. J Community Genet. 2012; 3(3): 221–228.
  10. Henneman L, Borry P, Chokoshvili D, et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet. 2016; 24(6): e1-e12.
  11. Capalbo A, Ramos-Alcalá L, Cimadomo D, et al. ESHG-ESHRE survey on the current practice of expanded carrier screening in European MAR centres. Hum Reprod. 2024; 39(8): 1844–1855.
  12. De Jong A, Dondorp WJ, de Die-Smulders CE, et al. Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet. 2010; 18(3): 272–277.
  13. Ministry of Health of the Russian Federation. Order No. 1130n of 20.10.2020 on the procedure for providing medical care in obstetrics and gynaecology [Ob utverzhdenii Poryadka okazaniya meditsinskoy pomoshchi po profilyu «akusherstvo i ginekologiya»]. Available from: https://www.consultant.ru/document/cons_doc_LAW_367763/ (accessed: 18.03.2026). Russian.
  14. Baranova EE, Izhevskaya VL, Efremova EE. Eticheskiye aspekty neinvazivnogo prenatal’nogo testirovaniya: avtonomiya i informirovannyy vybor. Meditsinskaya Genetika. 2024; 23(3): 12–20. Russian.
  15. Potapov AA, Kaplanova MT, Galaktionova AM, et al. Eticheskiye aspekty primeneniya polnogenomnogo neinvazivnogo prenatal’nogo testirovaniya. Meditsinskaya Genetika. 2023; 22(11): 3–12. Russian.
  16. Rim JH, Kim JH, Park JH, et al. Clinical pharmacogenetic testing and application: a guideline update. Ann Lab Med. 2024; 44(6): 494–512.
  17. Meslin EM, Kant C, Mazzuri S, Knoppers BM. Prenatal therapies: a Points to Consider framework for responsible innovation. BMC Med Genomics. 2025; 18(1): 191.
  18. Lynn AY, Farmer DL. The technical and ethical framework of fetal therapy. Curr Opin Pediatr. 2024; 36(3): 367–373.
  19. Aseyev MV, Baranov VS, Baranova EV, et al., eds. Evolyutsiya prediktivnoy meditsiny Saint Petersburg. Eko-Vektor. 2021; 359 p. Russian.
  20. Baranov VS. Genomika i prediktivnaya meditsina. Sibirskiy zhurnal klinicheskoy i eksperimental’noy meditsiny. 2021; 36(4): 14–28. Russian.
  21. Kurskaya SA. Pravo ne znat’ geneticheskuyu informatsiyu o sebe: imeyet li mesto v rossiyskom zakonodatel’stve. Yuridicheskiy mir. 2025; (4): 32–35. Russian.
  22. Guan ZW, Wu KJ, Bian HJ, et al. Pharmacogenetics of statins treatment: efficacy and safety. J Clin Pharm Ther. 2019; 44(6): 858–867.
  23. Raymond J, Dooley M, Singl N, et al. Pharmacogenetics of direct oral anticoagulants: a systematic review. J Pers Med. 2021; 11(1): 37.
  24. Muflih S, Al-Husein BA, Karasneh R, et al. Physicians’ attitudes and ethical obligations to pharmacogenetic testing. J Multidiscip Healthc. 2020; 13: 249–258.
  25. Greene BL, Nichols K, Parsons DW. Ethical considerations of genetic and genomic testing in pediatric oncology. CA Cancer J Clin. 2026; 76(2): e70005.